Association of LINC00673 rs11655237 polymorphism with cancer susceptibility: A meta-analysis based on 23,478 subjects.

BACKGROUND: Some studies on the relationship between LINC00673 polymorphism and cancer susceptibility have been inconsistent. To perform a more comprehensively quantitative assessment of LINC00673 rs11655237 and risk of overall cancer, we operated this meta-analysis for the first time. METHODS: A comprehensive search was conducted to obtain relevant literature up to November 20, 2019. Pooled odds ratios and 95% confidence intervals were utilized to assess rs11655237 and cancer susceptibility under five different genetic models. RESULTS: Eventually, 11 case-control studies from 9 articles were included. We found that LINC00673 rs11655237 polymorphism increased the susceptibility to overall cancer under all genetic models in the overall population. By dividing ethnicity and cancer type into subgroups, we also obtained similar positive results in subgroups of Chinese population, pancreatic cancer, cervical cancer, neuroblastoma, hepatoblastoma and gastric cancer. CONCLUSION: Overall, this meta-analysis has demonstrated for the first time that LINC00673 rs11655237 could increase susceptibility to cancer.

The Association Between Two Common Polymorphisms and Cancer Susceptibility: A Meta-Analysis.

BACKGROUND: Most studies revealed that microRNAs could play important roles in the development of various types of cancers. However, the findings remain inconsistent and controversial. To get more accurate results about the association of miR-26a-1 rs7372209 and miR-423 rs6505162 polymorphisms with risk of cancer, we conduct this meta-analysis. MATERIALS AND METHODS: We have searched relevant articles from the PubMed, Web of Science, Wanfang, and Chinese National Knowledge Infrastructure databases up to May 3, 2019. Pooled odds ratios (ORs) and 95% confidence intervals (CIs) were analyzed to assess the relationship between these two genetic polymorphisms and susceptibility to cancer. All statistical analyses were performed with Stata 12.0 software. RESULTS: Thirty-five articles were eligible in this meta-analysis, including 17,746 cases and 21,808 controls. Our results suggested that the miR-26a-1 rs7372209 polymorphism was associated with the susceptibility to overall cancer significantly in homozygote comparison and recessive model (TT versus CC: OR = 1.167, 95% CI: 1.025-1.329, P = 0.020; TT versus CT + CC: OR = 1.162, 95% CI: 1.025-1.318, P = 0.019). For miR-423 rs6505162, this study showed that the relationship between it and overall cancer susceptibility was statistically significant among five genetic models (CA versus CC: OR = 0.884, 95% CI: 0.806-0.969, P = 0.009; AA + CA versus CC: OR = 0.870, 95% CI: 0.789-0.959, P = 0.005; AA versus CA + CC: OR = 0.904, 95% CI: 0.827-0.988, P = 0.026; A versus C: OR = 0.899, 95% CI: 0.834-0.970, P = 0.006) rather than homozygote model. CONCLUSIONS: Rs7372209 in miR-26a-1 and rs6505162 in miR-423 are associated with overall cancer susceptibility.

Survival Outcome and Clinicopathologicl analysis of Homeobox gene cluster-embedded LncRNAs in Human Cancers: A Systematic Review and Meta-analysis.

OBJECTIVE: The ectopic expression of Homeobox (HOX) gene cluster-embedded long non-coding RNAs (LncRNAs) have been involved several carcinogenic development and progressions. This meta-analysis aimed to summarize the LncRNAs to validate the functions and the prognostic values in several kinds of cancer. METHODS: The retrospective study was conducted to analyze the association between HOX gene-related LncRNAs and the survival outcomes. Cochran's Q and I2 test were used for calculated heterogeneity, and I2 > 50%, P < 0.05 was conformed to the random effect model. Publication bias was indicated by Begg's and Egger's test. RESULTS: Total 15,315 patients extracting from 121 studies focused on assessing the association between LncRNAs and the survival outcomes and 12,110 participants were enrolled to address the clinicopathological features. The results demonstrated that the overexpression of HOX gene cluster-embedded LncRNAs revealed notable association among tumor size (pooled OR = 1.80), lymph node metastasis (LNM) stage (pooled OR = 3.00), tumor node metastasis (TNM) stage (pooled OR = 2.86), histological differentiation (pooled OR = 1.59) and distant metastasis (pooled OR = 2.49). Additionally, the up-regulated LncRNAs predicted a poor prognosis in overall survival (pooled HR = 1.95, 95%CI = 1.86-2.04), and also disclosed worse prognosis among the stratified analysis included HOX clusters, LncRNAs, ethnicity, and tumor classification (pooled HRs >1). CONCLUSION: In summary, the findings proved that HOX gene cluster-embedded LncRNAs acted as potential biomarkers for clinical treatment of several tumors and the overexpression might be a candidate hallmark for prognosis outcome.

Genetic Polymorphisms of PRNCR1 and Lung Cancer Risk in Chinese Northeast Population: A Case-Control Study and Meta-Analysis.

Long noncoding RNAs (lncRNAs) play vital roles in development and progression of various cancers. To investigate the relationship between three tag single-nucleotide polymorphisms (SNPs) (rs13252298, rs1016343, and rs1456315) in lncRNA prostate cancer-associated noncoding RNA 1 (PRNCR1) and lung cancer (LC) risk, we conducted this study. First, we performed a case-control study, including 576 LC patients and 612 cancer-free controls. Second, a meta-analysis was used to evaluate the association of selected SNPs with risk of overall cancer. We found that rs13252298 and rs1456315 were strongly correlated with risk of LC, nonsmall cell lung cancer (NSCLC), and lung adenocarcinoma. For rs13252298, individuals carrying GG genotype had increased risks of LC compared with those carrying AA genotype (adjusted odds ratio [OR] = 1.565, 95% CI = 1.091-2.245, p = 0.015). A significant result was also found in recessive model with adjusted OR of 1.719. Individuals with GG genotype of rs1456315 were at increased risks of LC compared with those carrying AA genotype. Similar results were found in NSCLC patients. Meta-analysis showed that rs1016343 and rs13252298 were associated with overall cancer. But for rs1016343, no significant association was observed in Asians. In conclusion, rs13252298 and rs1456315 in PRNCR1 may be genetic susceptibility factors for LC in Chinese population. These results need to be confirmed by further studies.

Candidate lncRNA-microRNA-mRNA networks in predicting non-small cell lung cancer and related prognosis analysis.

PURPOSE: The role of non-coding RNA, once thought to be dark matter, is increasingly prominent in cancer. Our article explores the effect of non-coding RNA in lung adenocarcinoma and lung squamous cell carcinoma by mining TCGA public database. METHODS: Download the data by applying the official TCGA software. The data were analyzed by R data analysis packages, 'edgeR', 'gplots' and 'survival'. We better illustrate the potential networks of lung cancer genes by constructing ceRNAs, using Cytoscape software. RESULTS: We obtained genes which were differentially expressed in lung adenocarcinoma and lung squamous cell carcinoma analysis. Within these differentially expressed genes, we also conducted a survival analysis to find differentially expressed genes associated with prognosis in both lung adenocarcinoma and lung squamous cell carcinoma. Based on genes differentially expressed of both lung adenocarcinoma and lung squamous cell carcinoma, we constructed a ceRNA network to illustrate the mechanism of lung adenocarcinoma and lung squamous cell carcinoma. Our study analyzed genes which were differentially expressed in lung adenocarcinoma and lung squamous cell carcinoma using the TCGA database. CONCLUSION: Based on this, the prognosis in both lung squamous cell carcinoma and lung adenocarcinoma was analyzed. We have also constructed a ceRNA network to provide a basis for the study of ceRNA in lung adenocarcinoma and lung squamous cell carcinoma.

Clinicopathological and prognostic significance of TINCR in caner: A meta-analysis.

BACKGROUND: In a variety of cancers, the expression of TINCR is linked to the development, progression, metastasis, invasion, and prognosis of cancer. Our study is the first study used meta-analysis to explore the relationship between TINCR expression and cancer. METHODS: By looking up PubMed, Web of Science, CNKI database, we obtained 10 articles for analysis. The statistical analysis was all calculated by Stata 15.1 software. RESULTS: We found that the expression of TINCR was a risk factor to the size of the tumor (OR = 1.772, 95%CI: 1.246-2.520, P = 0.001). In univariate analysis, patients with high expression of TINCR had poor OS (pooled HR = 1.533, 95%CI: 1.025-2.294, P = 0.038). Similar result was also found in multivariate analysis In subgroup analysis (pooled HR = 1.610, 95%CI: 1.356-1.913, P = 0.000).We also found that over-expression of TINCR had poor OS in breast cancer (pooled HR = 1.582, 95%CI: 1.126-2.223, P = 0.008). CONCLUSION: In this study, we found that over-expression of TINCR may influence the tumor size and contribute to the poor prognosis of cancer.

[The change of renin, endothelin and prostaglandin in blood during long time left ventricular assist].

OBJECTIVE: To monitor the change of renin, endothelin and 6-keto-prostaglandin F1alpha in canine during left ventricular assist (LVA). METHODS: Eight canines were assisted by left assist ventricular device for 9 hours. The level of renin, endothelin and 6-keto-prostaglandin f1alpha in plasma were measured by radioimmunity analysis before assisting (control group) and at 3 hours, at 6 hours, at 9 hours after assisting. RESULTS: The level of endothelin in plasma didn't dropped remarkably as LVA proceeded in which there was not differency in statistical diffency compared with control group[(51 +/- 11) ng/L, (42 +/- 8) ng/L, t = 0.926, P > 0.05]; The level of renin in plasma reached the summit at 3 hours during LVA compared with control group (3,036 +/- 1,411) ng/L, (1,783 +/- 467) ng/L, t = 5.013, P < 0.01) and later show dropping tendency without statistical differency at 9 hours (1 944 +/- 883) ng/L (t = 0.644, P > 0.05); The level of 6-keto-prostaglandin f1alpha in plasma at 3 hours during assisting increased remarkably [(75 +/- 17) ng/L, t = 1.411, P < 0.05), at 6 hours reached summit [(92 +/- 18)ng/L, t = 3.533, P < 0.01) and at 9 hours show dropping tendency with significant differency compared with control group (90 +/- 22) ng/L, t = 2.516, P < 0.05). CONCLUSION: During 9 hours LVA, endothelin didn't dropped remarkably compared with control group and the endothelium released renin with transient increase, prostaglandin with consistent increase.

[In vivo and in vitro evaluation of inflow cannula of left ventricular assist].

OBJECTIVE: To develop an inflow cannula of left ventricular assist implanted by blood vessel. METHODS: The maximum inflow and properties against folding of 8 sorts of cannulae were measured in mimic extracorporeal circulation appliances and canines. RESULTS: The maximum flow of the cannula increased, as the inner diameter became greater (P < 0.01) compared with each group. The maximum flow rate was (1.82 +/- 0.03) L/min, (2.44 +/- 0.03) L/min, (3.02 +/- 0.04) L/min, (3.31 +/- 0.03) L/min respectively for polyvinyl cannulae with wall thickness of 0.5 mm (PV 0.5 cannula) and inner diameter of 3 mm, 4 mm, 5 mm, 6 mm; (1.83 +/- 0.03) L/min, (3.07 +/- 0.04) L/min respectively for the polyvinyl chloride cannula with wall thickness of 1.0 mm imbedded by spring wire (PVCSW 1.0) and inner diameter of 3 mm and 5 mm; (1.82 +/- 0.02) L/min, 1.84 +/- 0.02 L/min for strengthened polyvinyl cannula with wall thickness of 0.8 mm (SPV 0.8) and inner diameter of 3 mm and polyvinyl cannula with wall thickness of 1.0 mm (PV 1.0 cannula) of inner diameter of 3 mm. There was no remarked statistical difference in vitro maximum flow among the four cannulae of 3 mm inner diameter in vitro. PVCSW 1.0 was showed the best antifolding property, PV 1.0 cannula good and SPV 0.8 and PV 0.5 unsatisfactory in properties against fold. There was no significant statistical difference between in vivo and in vitro maximum flow for PVCSW 1.0 and PV 1.0 cannulae of 3 mm inner diameter. But for SPV 0.8 and PV 0.5 cannulae of 3 mm inner diameter, there was a significant difference between in vivo and in vitro. CONCLUSIONS: PV 0.5 cannula and SPV 0.8 cannula are not suitable to clinical use. PV 1.0 cannula can be used in clinics. PVCSW 1.0 cannula is fully qualified for inflow conduit of left ventricular assist in surgery.